Thrombocytopenia Caused by Abciximab or Tirofiban and Its Association With Clinical Outcome in Patients Undergoing Coronary Stenting

Circulation - United States
doi 10.1161/01.cir.0000127867.41621.85
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Anemia and Its Association With Clinical Outcome in Heart Failure Patients Undergoing Cardiac Resynchronization Therapy

Journal of Interventional Cardiac Electrophysiology
MedicineCardiovascular MedicinePhysiologyCardiology
2015English

Intracoronary or Intravenous Abciximab After Aspiration Thrombectomy in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention

Cardiovascular Journal of Africa
MedicineCardiovascular MedicineCardiology
2019English

Two-Year Clinical Outcome After Abciximab-Coated Stent Implantation in Patients With Coronary Artery Disease

Circulation Journal
MedicineCardiovascular MedicineCardiology
2010English

No Association of ABCB1 C3435T Genotype With Clopidogrel Response or Risk of Stent Thrombosis in Patients Undergoing Coronary Stenting

Circulation: Cardiovascular Interventions
Cardiovascular MedicineCardiology
2012English

Abciximab Attenuates Coronary Microvascular Endothelial Dysfunction After Coronary Stenting

Circulation
Cardiovascular MedicinePhysiologyCardiology
2002English

Are Tirofiban and Abciximab Identical in Efficacy?

European Heart Journal
Cardiovascular MedicineCardiology
2005English

Clinical Outcome Following Coronary Angioplasty in Dialysis Patients: A Case-Control Study in the Era of Coronary Stenting

Heart
2001English

Mild Renal Disease Increases Major Bleeding in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Stenting

Thrombosis and Haemostasis
Hematology
2012English

C-Reactive Protein in Canine Babesiosis Caused by Babesia Rossi and Its Association With Outcome : Article

Journal of the South African Veterinary Association
MedicineVeterinary
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy